Search

everythinglearnresearchcommunity

for

Search:↓

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

ZD1839 can cause skin issues like acne and hair changes.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Pexidartinib often causes liver issues and fatigue, especially in women.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.